To answer this question, we treated ovarian carcinoma cells with increasing concentrations of 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) a PLD pharmacological inhibitor for 6 and 24 h. This evidence concerns the gene GPLD1 and ovarian carcinoma.